GLI1 and Ewing sarcoma: Altogether, these results identify Gli1 as a promising therapeutic target in Ewing sarcoma and demonstrate that GANT61, through inhibition of Gli1 transcriptional activity, may be a promising therapeutic strategy hindering ES tumor progression, specifically primary tumor growth.